Fol. Biol. 2011, 57, 30-34
https://doi.org/10.14712/fb2011057010030
Polymorphisms in IFN-γ, TNF-α and IL-10 in Patients on Maintenance Haemodialysis
References
1. , M., Shibuya, A., Yasuda, M., Azuma, N., Tsuchiya, K., Akiba, T., Nitta, K. (2005) Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 20, 2497-2503.
<https://doi.org/10.1093/ndt/gfi048>
2. , V. S., Guo, D., Rao, M., Jaber, B. L., Tighiouart, H., Freeman, R. L., Huang, C., King, A. J., Pereira, B. J. G., The HEMO Study Group. (2004) Cytokine gene polymorphisms in hemodialysis patients: Association with comorbidity, functionality, and serum albumin. Kidney Int. 65, 1449-1460.
<https://doi.org/10.1111/j.1523-1755.2004.00531.x>
3. , G., Amoroso, A., Savoldi, S., Bosutti, A., Martone, M., Pirulli, D., Bianco, F., Ulivi, S., Bertok, S., Artero, M., Barazzoni, R., Zanetti, M., Grassi, G., Guarnieri, G., Panzetta, G. (2006) Association of interferon-γ +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol. Dial. Transplant. 21, 1317-1322.
<https://doi.org/10.1093/ndt/gfk033>
4. , I., Petrasek, J., Hribova, P., Hyklova, K., Bartosova, K., Lacha, J., Viklicky, O. (2007) Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 84, 1037-1044.
<https://doi.org/10.1097/01.tp.0000285295.39275.3b>
5. , A. C., Mikhail, A., Lethbridge, M. W., Kemeny, D. M., Macdougall, I. C. (2003) Increased expression of erythropoiesis cytokines (IFN-γ, TNF-α, IL-10 and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J. Am. Soc. Nephrol. 14, 1776-1784.
<https://doi.org/10.1097/01.ASN.0000071514.36428.61>
6. , E., Lima, M., Alves, J. M., Rocha, S., Rocha-Pereira, P., Castro, E., Miranda, V., do S. F., Loureiro, A., Quintanilha, A., Belo, L., Santos-Silva, A. J. (2008) Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J. Clin. Immunol. 28, 268-275.
<https://doi.org/10.1007/s10875-007-9168-x>
7. , Y., Kurashige, S., Hashimoto, S., Suzuki, S. (1999) Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron 83, 237-245.
<https://doi.org/10.1159/000045516>
8. , A. L. M., Stenvinkel, P., Vaulont, S. (2009) Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. NDT Plus 2 (Suppl 1), i18-i26.
<https://doi.org/10.1093/ndtplus/sfn176>
9. , M. (2002) Humoral immune responses in uremia and the role of IL-10. Blood Purif. 20, 485-488.
<https://doi.org/10.1159/000063553>
10. , M., Kaul, H., Sester, U., Ulrich, C., Sester, M., Georg, T., Köhler, H. (2002) Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 62, 949-955.
<https://doi.org/10.1046/j.1523-1755.2002.00504.x>
11. , M., Ulrich, C., Kaul, H., Sester, U., Sester, M., Köhler, H. (2003) Uremia-associated immune defect: The IL-10CRP axis. Kidney Int. Suppl. 84, S76-79.
<https://doi.org/10.1046/j.1523-1755.63.s84.14.x>
12. , M., Heine, G. H., Köhler, H., DialGene Consortium. (2006) Gene polymorphism association studies in dialysis: anemia and host immunity. Semin. Dial. 19: 227-31.
13. , X., Kitamoto, S., Lian, Q., Boisvert, W. A. (2009) Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J. Biol. Chem. 284, 32950-32958.
<https://doi.org/10.1074/jbc.M109.040899>
14. , H., Qureshi, A. R., Heimbürger, O., Barany, P., Wang, K., Pecoits-Filho, R., Stenvinkel, P., Lindholm, B. (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis. 47, 139-148.
<https://doi.org/10.1053/j.ajkd.2005.09.014>
15. , J. A., Bloudickova, S., Kubinova, R., Pikhart, H., Viklicky, O., Bobak, M. (2009) Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls. Biochem. Genet. 47, 688-693.
<https://doi.org/10.1007/s10528-009-9266-y>
16. , K., McAllister, C. J., Lehn, R. S., Lee, G. H., Nissenson, A. R., Kopple, J. D. (2003) Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am. J. Kidney Dis. 42, 761-773.
<https://doi.org/10.1016/S0272-6386(03)00915-6>
17. , N. H., Huisman, M., van den Dorpel, M., Betjes, M. G. (2008) Impaired immune responses and antigen-specific memory CD4+ T cells in haemodialysis patients. J. Am. Soc. Nephrol. 19, 1483-1490.
<https://doi.org/10.1681/ASN.2007090971>
18. , H., Werdan, K., Buerke, M. (2008) Vascular cells contribute to atherosclerosis by cytokineand innate-immunity-related inflammatory mechanisms. Innate Immun. 14, 63-87.
<https://doi.org/10.1177/1753425908091246>
19. , I. C., Cooper, A. C. (2002) Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol. Dial. Transplant. 17 (Suppl 11), 39-43.
<https://doi.org/10.1093/ndt/17.suppl_11.39>
20. , V., Greene, T., Wang, X., Pereira, A. A., Marcovina, S. M., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., Sarnak, M. J. (2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 68, 766-772.
<https://doi.org/10.1111/j.1523-1755.2005.00455.x>
21. , S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
<https://doi.org/10.1093/nar/16.3.1215>
22. , I. K., Szaba, F. M., Kummer, L. W., Wilhelm, L. B., Parent, M. A., Johnson, L. L., Smiley, S. T. (2007) γ-interferon suppresses erythropoiesis via interleukin-15. Infect. Immun. 75, 2630-2633.
<https://doi.org/10.1128/IAI.01836-06>
23. , J., Hodge, G., Henning, P. (2006) Intracellular cytokines in peripheral blood leucocytes in children with chronic renal failure. Pediatr. Nephrol. 21, 251-256.
<https://doi.org/10.1007/s00467-005-2096-1>
24. , A., Bustos, C., Alonso, J., Alcázar, R., LópezArmada, M. J., Plaza, J. J., González, E., Egido, J. (1995) Involvement of tumor necrosis factor-α in the pathogenesis of experimental and human glomerulonephritis. Adv. Nephrol. Necker Hosp. 24, 53-77.
25. , G., Pljesa, S., Rasic-Milutinovic, Z., Stankovic, S., Ilic, M., Maletic, R. (2008) Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis. Can. J. Physiol. Pharmacol. 86, 205-209.
<https://doi.org/10.1139/Y08-018>
26. , P., Tripathi, G., Sharma, R. K., Sankhwar, S. N., Agrawal, S. (2009) Role of non-HLA genetic variants in end-stage renal disease. Tissue Antigens 74, 147-155.
<https://doi.org/10.1111/j.1399-0039.2009.01276.x>
27. , N., Karayaylali, I., Balal, M., Paydas, S., Aikimbaev, K., Cetiner, S., Seydaoglu, G. (2005) Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients? Scand. J. Urol. Nephrol. 39, 405-409.
<https://doi.org/10.1080/00365590500386734>
28. , P. (2001) The role of inflammation in the anaemia of end-stage renal disease. Nephrol. Dial. Transplant. 16 (Suppl 7), 36-40.
<https://doi.org/10.1093/ndt/16.suppl_7.36>
29. , P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., Girndt, M. (2005) IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia: The good, the bad, and the ugly. Kidney Int. 67, 1216-1233.
<https://doi.org/10.1111/j.1523-1755.2005.00200.x>
30. , P. (2006a) Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 11, 36-41.
<https://doi.org/10.1111/j.1440-1797.2006.00541.x>
31. , P. (2006b) New insights on inflammation in CKDgenetic and non-genetic factors. Nephrol. Ther. 2, 111-119.
<https://doi.org/10.1016/j.nephro.2006.04.004>
